• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

及时的剃须刀治疗可消除慢性痛风石肿块并改善手术效果。

Timely Shaver Treatment Removes Chronic Tophaceous Mass Improve Surgical Outcomes.

作者信息

Yen Patrick Szu-Ying, Tu Hung-Pin, Huang Shu-Hung, Lee Su-Shin

机构信息

School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Public Health and Environmental Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Taiwan.

出版信息

Int J Med Sci. 2024 Jul 9;21(10):1799-1805. doi: 10.7150/ijms.95372. eCollection 2024.

DOI:10.7150/ijms.95372
PMID:39113890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11302556/
Abstract

Current treatments with urate-lowering therapy (ULT) are effective for most patients with gout. However, approximately 10% of these patients do not respond well to ULT and develop chronic tophus lesions. This study aimed to evaluate the efficacy of surgery involving the shaver technique against chronic tophus lesions. This single-center, retrospective cohort study included 217 patients who had cumulatively undergone 303 shaver-assisted procedures between 2002 and 2018. Surgical outcomes were assessed in terms of the length of hospital stay (LOS) and wound healing time. LOS and wound healing time were longer in patients with a preoperative tophus infection and lower extremity lesions than in those without infection and with upper extremity lesions (respectively, LOS: 12.7 vs. 8.6 days; wound healing time: 22.7 vs. 16.3 days). However, factors such as age, sex, body mass index, renal function, or uricemia level exerted no significant effect on surgical outcomes. Surgery involving the shaver technique should be performed before tophus infection. Clinical outcomes tend to be better for upper extremity lesions than for lower extremity lesions.

摘要

目前的降尿酸治疗(ULT)对大多数痛风患者有效。然而,这些患者中约有10%对ULT反应不佳,并出现慢性痛风石病变。本研究旨在评估采用刨削技术的手术治疗慢性痛风石病变的疗效。这项单中心回顾性队列研究纳入了217例患者,他们在2002年至2018年间累计接受了303次刨削辅助手术。根据住院时间(LOS)和伤口愈合时间评估手术结果。术前有痛风石感染和下肢病变的患者的LOS和伤口愈合时间比无感染和上肢病变的患者更长(LOS分别为:12.7天对8.6天;伤口愈合时间为:22.7天对16.3天)。然而,年龄、性别、体重指数、肾功能或血尿酸水平等因素对手术结果没有显著影响。应在痛风石感染前进行采用刨削技术的手术。上肢病变的临床结果往往优于下肢病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c7/11302556/40eb1c8d12e8/ijmsv21p1799g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c7/11302556/b7270305ba82/ijmsv21p1799g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c7/11302556/40eb1c8d12e8/ijmsv21p1799g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c7/11302556/b7270305ba82/ijmsv21p1799g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c7/11302556/40eb1c8d12e8/ijmsv21p1799g002.jpg

相似文献

1
Timely Shaver Treatment Removes Chronic Tophaceous Mass Improve Surgical Outcomes.及时的剃须刀治疗可消除慢性痛风石肿块并改善手术效果。
Int J Med Sci. 2024 Jul 9;21(10):1799-1805. doi: 10.7150/ijms.95372. eCollection 2024.
2
Timing of intra-lesion shaving for surgical treatment of chronic tophus.慢性痛风石皮损内削术治疗的时机。
J Plast Reconstr Aesthet Surg. 2013 Aug;66(8):1131-7. doi: 10.1016/j.bjps.2013.03.041. Epub 2013 May 21.
3
Surgical treatment of the chronic tophaceous deformity in upper extremities - the shaving technique.上肢慢性痛风石性畸形的手术治疗——刮除技术
J Plast Reconstr Aesthet Surg. 2009 May;62(5):669-74. doi: 10.1016/j.bjps.2007.12.021. Epub 2008 Jan 28.
4
The soft-tissue shaving procedure for deformity management of chronic tophaceous gout.用于慢性痛风石性痛风畸形处理的软组织刮除术。
Ann Plast Surg. 2003 Oct;51(4):372-5. doi: 10.1097/01.SAP.0000067723.32532.97.
5
Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.常规入院前降尿酸治疗和血清尿酸检测与痛风患者的住院时间缩短相关:一项全国范围内基于人群的队列研究。
Int J Rheum Dis. 2022 Feb;25(2):154-162. doi: 10.1111/1756-185X.14250. Epub 2021 Nov 18.
6
Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.下肢慢性肢体威胁性缺血的初次搭桥术与初次血管成形术/支架置入术的结果。
J Vasc Surg. 2017 Aug;66(2):466-475. doi: 10.1016/j.jvs.2017.01.024. Epub 2017 Mar 6.
7
The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma.术前放疗与手术切除之间的时间间隔对肢体软组织肉瘤伤口愈合并发症发生情况的影响。
Ann Surg Oncol. 2015 Sep;22(9):2824-30. doi: 10.1245/s10434-015-4631-z. Epub 2015 May 28.
8
A survey of indications, results and complications of surgery for tophaceous gout.痛风石性痛风手术的适应证、结果及并发症调查
N Z Med J. 2002 Jul 26;115(1158):U109.
9
Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.Lesinurad 联合非布司他治疗痛风石性痛风患者的延长治疗期间的疗效和安全性:CRYSTAL 扩展研究。
Arthritis Res Ther. 2019 Jan 7;21(1):8. doi: 10.1186/s13075-018-1788-4.
10
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.培戈洛酶治疗慢性痛风患者难治性疾病:来自 3 期随机临床试验和开放标签扩展研究的尿酸盐结晶负担减轻结果。
Arthritis Res Ther. 2013 Sep 26;15(5):R137. doi: 10.1186/ar4318.

本文引用的文献

1
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.比较起始目标治疗的别嘌醇和非布司他与痛风发作:一项随机多中心试验的事后分析。
Arthritis Rheumatol. 2024 Oct;76(10):1552-1559. doi: 10.1002/art.42927. Epub 2024 Jul 15.
2
Untreated Chronic Gout.未经治疗的慢性痛风
N Engl J Med. 2021 Dec 30;385(27):e97. doi: 10.1056/NEJMicm2112548. Epub 2021 Dec 25.
3
Update on gout management: what is old and what is new.痛风管理的最新进展:旧有与新见。
Curr Opin Rheumatol. 2022 Mar 1;34(2):118-124. doi: 10.1097/BOR.0000000000000861.
4
Enhancing wound healing dressing development through interdisciplinary collaboration.通过跨学科合作促进伤口愈合敷料的开发。
J Biomed Mater Res B Appl Biomater. 2021 Dec;109(12):1967-1985. doi: 10.1002/jbm.b.34861. Epub 2021 May 17.
5
Differential Therapeutic Effect of Extracellular Vesicles Derived by Bone Marrow and Adipose Mesenchymal Stem Cells on Wound Healing of Diabetic Ulcers and Correlation to Their Cargoes.骨髓间充质干细胞和脂肪间充质干细胞来源的细胞外囊泡对糖尿病溃疡伤口愈合的差异治疗作用及其与囊泡内容物的相关性
Int J Mol Sci. 2021 Apr 8;22(8):3851. doi: 10.3390/ijms22083851.
6
Tophaceous Gout - When the Skin Comes First.痛风石 - 皮肤当先。
Acta Dermatovenerol Croat. 2020 Dec;28(7):223-227.
7
Synergistic Effects of Autologous Platelet-Rich Plasma and Hyaluronic Acid Injections on Facial Skin Rejuvenation.富血小板血浆和透明质酸注射对面部皮肤年轻化的协同作用。
Aesthet Surg J. 2021 Jun 14;41(7):NP854-NP865. doi: 10.1093/asj/sjab061.
8
Striae Distensae: In Vitro Study and Assessment of Combined Treatment With Sodium Ascorbate and Platelet-Rich Plasma on Fibroblasts.膨胀纹:抗坏血酸钠和富血小板血浆联合治疗对成纤维细胞的体外研究和评估。
Aesthetic Plast Surg. 2021 Jun;45(3):1282-1293. doi: 10.1007/s00266-020-02100-7. Epub 2021 Jan 20.
9
The Effect of Comorbidities on Wound Healing.合并症对伤口愈合的影响。
Surg Clin North Am. 2020 Aug;100(4):695-705. doi: 10.1016/j.suc.2020.05.002. Epub 2020 Jun 17.
10
Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations.聚乙二醇化尿酸酶在痛风治疗中的应用——安全性问题、最新证据及临床考量
Ther Adv Drug Saf. 2017 Dec;8(12):379-388. doi: 10.1177/2042098617727714. Epub 2017 Sep 13.